Immunocore Holdings (IMCR) Prepaid Assets (2022 - 2026)
Immunocore Holdings' (IMCR) quarterly Prepaid Assets came in at $69.6 million in Q1 2026, up 66.89% year-on-year from $41.7 million in Q1 2025, and up 34.16% quarter-over-quarter from $51.9 million in Q4 2025.
Immunocore Holdings (IMCR) Prepaid Assets (2022 - 2026) Analysis & Trends
Immunocore Holdings has disclosed Prepaid Assets across 5 years of filings, most recently posting $69.6 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $69.6 million, up 66.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $69.6 million (up 66.89% YoY), and the FY2025 annual result was $51.9 million, up 26.41% from the prior year.
- Prepaid Assets came in at $69.6 million for Q1 2026 at Immunocore Holdings, up from $51.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $69.6 million in Q1 2026 to a low of $10.1 million in Q4 2022.
- The 5-year median for Prepaid Assets is $41.0 million (2024), against an average of $39.9 million.
- Across the five-year window, Prepaid Assets surged 192.81% in 2023 and rose 26.41% in 2025, its largest moves.
- Immunocore Holdings' Prepaid Assets stood at $10.1 million in 2022, then surged by 192.81% to $29.6 million in 2023, then soared by 38.62% to $41.0 million in 2024, then grew by 26.41% to $51.9 million in 2025, then surged by 34.16% to $69.6 million in 2026.
- The last three Prepaid Assets figures came in at $69.6 million (Q1 2026), $51.9 million (Q4 2025), and $49.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - |
| 10 | Immunocore Holdings | 1.46 Bn | 616.35 Mn | 106.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.59 Mn |
| Dec 31, 2025 | 51.87 Mn |
| Sep 30, 2025 | 48.96 Mn |
| Jun 30, 2025 | 44.27 Mn |
| Mar 31, 2025 | 41.70 Mn |
| Dec 31, 2024 | 41.03 Mn |
| Sep 30, 2024 | 36.45 Mn |
| Jun 30, 2024 | 33.56 Mn |
| Mar 31, 2024 | 31.30 Mn |
| Dec 31, 2023 | 29.60 Mn |
| Dec 31, 2022 | 10.11 Mn |